Skip to content

Glycine in Cerebrospinal Fluid (CSF)

Published: August 9, 2026Updated: August 16, 2026

This test measures the amount of glycine, an amino acid, found in your cerebrospinal fluid (the fluid surrounding your brain and spinal cord). It may be checked to evaluate conditions affecting the central nervous system.

Quick summary

["Glycine levels in CSF can help diagnose or monitor certain neurological conditions."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
33213-0
Short code
Glycine Plas/CSF
Synonyms
Glycine Plas/CSF
Category
glucose
Sample
plasma
Container
Lavender-top (EDTA) or Green-top (Heparin)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms like headaches, seizures, or neurological issues that suggest an abnormality in your brain or spinal fluid. It could also be part of a broader evaluation for conditions like meningitis, brain tumors, or metabolic disorders affecting the nervous system.

What to Expect Before the Test

No special preparation is usually needed. You may be asked to lie down on an examination table while a needle is inserted into your back or neck to collect a small sample of CSF. This procedure is typically done in a hospital or clinic setting and may cause mild discomfort.

What the Test Results Mean

Abnormal glycine levels in CSF can indicate underlying issues such as certain genetic disorders, metabolic problems, or conditions affecting the production or breakdown of amino acids in the brain. However, interpretation depends on clinical context and other test results.

Common Conditions Monitored

While glycine in CSF isn’t as commonly monitored as other CSF tests (like protein or glucose), elevated or low levels may be associated with rare genetic disorders or metabolic diseases that impact amino acid metabolism in the central nervous system.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

CSF Glycine

Frequently asked questions

What Causes Abnormal Results?
Abnormal glycine levels in CSF can result from genetic metabolic disorders (e.g., glycineuria), certain neurological infections, or rare congenital conditions affecting amino acid processing. Always discuss results with your doctor, as they’ll consider your full medical history and other tests.
How Are Results Interpreted?
Your doctor will compare your glycine level to reference ranges relevant to your age, health, and condition. Since glycine reference ranges in CSF aren’t standardized, results are evaluated alongside symptoms and other diagnostic findings.
When Might Follow-Up Be Needed?
If glycine levels are abnormal, further testing (e.g., genetic evaluation, metabolic studies) may be recommended to identify the underlying cause. Follow-up with your healthcare provider is essential to address any concerns or next steps.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy